Literature DB >> 14688116

Intracellular growth of Trypanosoma cruzi in cardiac myocytes is inhibited by cytokine-induced nitric oxide release.

Laura Edith Fichera1, Maria Cecilia Albareda, Susana Adriana Laucella, Miriam Postan.   

Abstract

The effect of interleukin-1beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) on Trypanosoma cruzi multiplication and nitric oxide (NO) production in cardiac myocytes was investigated. Cardiac myocyte cultures were obtained from neonatal Wistar rat hearts, infected with T. cruzi, and treated with IL-1beta, TNF-alpha, IFN-gamma, or N-monomethyl-L-arginine (L-NAME) for 72 h. Parasite growth was calculated from the number of infected cells in Giemsa-stained smears. Nitric oxide production was determined with the Griess reagent. Inducible nitric oxide synthase (iNOS) expression by cardiac myocytes was detected by Western blot. The results showed that the percentages of cardiac myocytes containing T. cruzi amastigotes in cytokine-treated cultures were significantly lower than in nontreated cultures. The addition of L-NAME reversed the inhibitory effect on parasite growth of IL-1beta and TNF-alpha but not of IFN-gamma. Nitrite levels released by T. cruzi-infected and noninfected cardiac myocyte cultures after 72 h of stimulation with IL-1beta were significantly higher than those produced upon treatment with TNF-alpha, IFN-gamma, or medium alone, regardless of the infection status. Nitrite levels in TNF-alpha-stimulated infected cultures were significantly higher than in untreated infected cultures and TNF-alpha-treated noninfected cultures. L-NAME inhibited IL-1beta- but not TNF-alpha-induced NO production, indicating the presence of iNOS-dependent and iNOS-independent mechanisms for NO formation in this experimental system. iNOS expression was detected in infected and noninfected cardiac myocytes stimulated with IL-1 beta and TNF-alpha but not with IFN-gamma. These results suggest an important role for cardiac myocytes and locally secreted cytokines in the control of parasite multiplication in T. cruzi-induced myocarditis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688116      PMCID: PMC343980          DOI: 10.1128/IAI.72.1.359-363.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways.

Authors:  L G Bekker; S Freeman; P J Murray; B Ryffel; G Kaplan
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  Cardiac myocyte hypertrophy and proliferating cell nuclear antigen expression in Wistar rats infected with Trypanosoma cruzi.

Authors:  María Rosa Arnaiz; Laura Edith Fichera; Miriam Postan
Journal:  J Parasitol       Date:  2002-10       Impact factor: 1.276

Review 3.  Nitric oxide synthase-independent generation of nitric oxide in muscle ischemia--reperfusion injury.

Authors:  D A Lepore
Journal:  Nitric Oxide       Date:  2000-12       Impact factor: 4.427

4.  [Myocardial cell response to Trypanosoma cruzi infection].

Authors:  M Postan; M R Arnaiz; L E Fichera
Journal:  Medicina (B Aires)       Date:  1999       Impact factor: 0.653

Review 5.  Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis.

Authors:  Kai C Wollert; Helmut Drexler
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

6.  Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity.

Authors:  F S Machado; G A Martins; J C Aliberti; F L Mestriner; F Q Cunha; J S Silva
Journal:  Circulation       Date:  2000-12-12       Impact factor: 29.690

Review 7.  Non-enzymatic nitric oxide synthesis in biological systems.

Authors:  J L Zweier; A Samouilov; P Kuppusamy
Journal:  Biochim Biophys Acta       Date:  1999-05-05

8.  Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism.

Authors:  M A Muñoz-Fernández; M A Fernández; M Fresno
Journal:  Immunol Lett       Date:  1992-06       Impact factor: 3.685

9.  Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain).

Authors:  Madhulika Chandra; Herbert B Tanowitz; Stefka B Petkova; Huan Huang; Louis M Weiss; Murray Wittner; Stephen M Factor; Vitaliy Shtutin; Linda A Jelicks; John Chan; Jamshid Shirani
Journal:  Int J Parasitol       Date:  2002-06-15       Impact factor: 3.981

10.  Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction.

Authors:  M J Dallman; C P Larsen; P J Morris
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

View more
  14 in total

1.  In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease.

Authors:  Alisson L Matsuo; Luis S Silva; Ana C Torrecilhas; Bruno S Pascoalino; Thiago C Ramos; Elaine G Rodrigues; Sergio Schenkman; Antonio C F Caires; Luiz R Travassos
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

2.  The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi.

Authors:  Jenny L Hardison; Ruth A Wrightsman; Philip M Carpenter; William A Kuziel; Thomas E Lane; Jerry E Manning
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.

Authors:  María L Scalise; Eva C Arrúa; Marcela S Rial; Mónica I Esteva; Claudio J Salomon; Laura E Fichera
Journal:  Am J Trop Med Hyg       Date:  2016-05-31       Impact factor: 2.345

4.  Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs.

Authors:  Noelia L Grosso; Jacqueline Bua; Alina E Perrone; Mariela N Gonzalez; Patricia L Bustos; Miriam Postan; Laura E Fichera
Journal:  Exp Parasitol       Date:  2010-05-21       Impact factor: 2.011

5.  Neurobehavioral Toxicity Induced by Carbendazim in Rats and the Role of iNOS, Cox-2, and NF-κB Signalling Pathway.

Authors:  Yasmin A Ebedy; Eman I Hassanen; Ahmed M Hussien; Marwa A Ibrahim; M O Elshazly
Journal:  Neurochem Res       Date:  2022-03-21       Impact factor: 3.996

6.  The steady-state transcriptome of the four major life-cycle stages of Trypanosoma cruzi.

Authors:  Todd A Minning; D Brent Weatherly; James Atwood; Ron Orlando; Rick L Tarleton
Journal:  BMC Genomics       Date:  2009-08-07       Impact factor: 3.969

7.  Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.

Authors:  Jaline Coutinho Silverio; Luzia Maria de-Oliveira-Pinto; Andréa Alice da Silva; Gabriel Melo de Oliveira; Joseli Lannes-Vieira
Journal:  Int J Exp Pathol       Date:  2009-10-28       Impact factor: 1.925

8.  Pathogenesis of Chagas disease: time to move on.

Authors:  Fabiana S Machado; Kevin M Tyler; Fatima Brant; Lisia Esper; Mauro M Teixeira; Herbert B Tanowitz
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

9.  Interferon-γ restricts Toxoplasma gondii development in murine skeletal muscle cells via nitric oxide production and immunity-related GTPases.

Authors:  Anna C Takács; Izabela J Swierzy; Carsten G K Lüder
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

10.  Shotgun sequencing analysis of Trypanosoma cruzi I Sylvio X10/1 and comparison with T. cruzi VI CL Brener.

Authors:  Oscar Franzén; Stephen Ochaya; Ellen Sherwood; Michael D Lewis; Martin S Llewellyn; Michael A Miles; Björn Andersson
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.